陶氏的翻译后修改及其在阿尔茨海默氏症病理学的作用
Subha Kalyaanamoorthy1, Stanley Kojo Opare1, Xiaoxiao Xu1
1Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada.
Current Alzheimer research
|April 16, 2024
概括
蛋白的修改是阿尔茨海默病的关键.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 在阿尔茨海默氏病 (AD) 中,微管相关蛋白质tau (tau) 聚合物.
- 蛋白经历了广泛的翻译后修改 (PTMs),影响其功能和聚合.
- 在AD病理学中tau PTMs之间的相互作用尚未完全理解.
研究的目的:
- 审查关键的tau PTM及其在tau生理学和病理生理学中的联系.
- 探索计算建模在理解PTM对tau的影响中的作用.
- 为了突出TAU PTM为AD的治疗策略.
主要方法:
- 关于tau翻译后修改的文献综述.
- 对tau结构-功能计算建模方法的分析.
- 对针对tau PTMs的治疗策略的调查.
主要成果:
- PTMs显著影响蛋白质结构,溶解度和聚合.
- 不同的PTM之间的相互作用对于tau在AD中的作用至关重要.
- 计算模型为PTM介导的功能变化提供了洞察力.
- 目前正在研究针对tau PTM的各种治疗策略.
结论:
- 了解tau PTM的相互作用对于阐明AD的发病因子至关重要.
- 计算方法是研究tau PTMs的宝贵工具.
- 准tau PTM为阿尔茨海默病提供了有前途的治疗途径.
相关概念视频
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Phosphorylation
50.3K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.3K
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


